BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 11170910)

  • 1. Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation.
    Crippa F; Corey L; Chuang EL; Sale G; Boeckh M
    Clin Infect Dis; 2001 Jan; 32(2):214-9. PubMed ID: 11170910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes.
    Oshima K; Kanda Y; Kako S; Asano-Mori Y; Watanabe T; Motokura T; Chiba S; Shiraki K; Kurokawa M
    J Med Virol; 2008 Oct; 80(10):1769-75. PubMed ID: 18712833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for cytomegalovirus retinitis in patients with cytomegalovirus viremia after hematopoietic stem cell transplantation.
    Jeon S; Lee WK; Lee Y; Lee DG; Lee JW
    Ophthalmology; 2012 Sep; 119(9):1892-8. PubMed ID: 22657564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and outcomes of cytomegalovirus retinitis after transplantation.
    Eid AJ; Bakri SJ; Kijpittayarit S; Razonable RR
    Transpl Infect Dis; 2008 Feb; 10(1):13-8. PubMed ID: 17511815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: the HPMPC Peripheral Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
    AIDS; 2000 Jul; 14(11):1571-81. PubMed ID: 10983644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus ventriculoencephalitis in a bone marrow transplant recipient receiving antiviral maintenance: clinical and molecular evidence of drug resistance.
    Seo SK; Regan A; Cihlar T; Lin DC; Boulad F; George D; Prasad VK; Kiehn TE; Polsky B
    Clin Infect Dis; 2001 Nov; 33(9):e105-8. PubMed ID: 11577375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
    George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
    Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I study of combination therapy with intravenous cidofovir and oral ganciclovir for cytomegalovirus retinitis in patients with AIDS.
    Jacobson MA; Wilson S; Stanley H; Holtzer C; Cherrington J; Safrin S
    Clin Infect Dis; 1999 Mar; 28(3):528-33. PubMed ID: 10194072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections.
    Chakrabarti S; Collingham KE; Osman H; Fegan CD; Milligan DW
    Bone Marrow Transplant; 2001 Nov; 28(9):879-81. PubMed ID: 11781649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cidofovir for cytomegalovirus reactivation in pediatric patients after hematopoietic stem cell transplantation.
    Cesaro S; Zhou X; Manzardo C; Buonfrate D; Cusinato R; Tridello G; Mengoli C; Palù G; Messina C
    J Clin Virol; 2005 Oct; 34(2):129-32. PubMed ID: 16157264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus retinitis after hematopoietic stem cell transplantation with alemtuzumab.
    Song WK; Min YH; Kim YR; Lee SC
    Ophthalmology; 2008 Oct; 115(10):1766-70. PubMed ID: 18562004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal cytomegalovirus pneumonia after preemptive antiviral therapy in a renal transplant recipient.
    Ketteler M; Preuschof L; Mertz A; Stöffler-Meilicke M; Schäfer H; Distler A; Offermann G
    Clin Nephrol; 2000 Nov; 54(5):418-24. PubMed ID: 11105806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent occurrence of cytomegalovirus retinitis during immune reconstitution warrants regular ophthalmic screening in high-risk pediatric allogeneic hematopoietic stem cell transplant recipients.
    Hiwarkar P; Gajdosova E; Qasim W; Worth A; Breuer J; Chiesa R; Ridout D; Edelsten C; Moore A; Amrolia P; Veys P; Rao K
    Clin Infect Dis; 2014 Jun; 58(12):1700-6. PubMed ID: 24700657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic developments in cytomegalovirus retinitis.
    Hoffman VF; Skiest DJ
    Expert Opin Investig Drugs; 2000 Feb; 9(2):207-20. PubMed ID: 11060672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A deletion mutation in region V of the cytomegalovirus DNA polymerase sequence confers multidrug resistance.
    Chou S; Miner RC; Drew WL
    J Infect Dis; 2000 Dec; 182(6):1765-8. PubMed ID: 11069251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantation.
    Yanada M; Yamamoto K; Emi N; Naoe T; Suzuki R; Taji H; Iida H; Shimokawa T; Kohno A; Mizuta S; Maruyama F; Wakita A; Kitaori K; Yano K; Hamaguchi M; Hamajima N; Morishima Y; Kodera Y; Sao H; Morishita Y
    Bone Marrow Transplant; 2003 Oct; 32(8):801-7. PubMed ID: 14520425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The changing treatment options for CMV retinitis.
    Gilden D
    GMHC Treat Issues; 1995; 9(7/8):1-8. PubMed ID: 11362648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cidofovir in the treatment of cytomegalovirus (CMV) retinitis.
    Garcia CR; Torriani FJ; Freeman WR
    Ocul Immunol Inflamm; 1998 Sep; 6(3):195-203. PubMed ID: 9785611
    [No Abstract]   [Full Text] [Related]  

  • 19. A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients.
    Shereck EB; Cooney E; van de Ven C; Della-Lotta P; Cairo MS
    Pediatr Blood Cancer; 2007 Sep; 49(3):306-12. PubMed ID: 16972242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation.
    Almyroudis NG; Jakubowski A; Jaffe D; Sepkowitz K; Pamer E; O'Reilly RJ; Papanicolaou GA
    Transpl Infect Dis; 2007 Dec; 9(4):286-94. PubMed ID: 17511819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.